Diamond Biotechnology Co., Ltd (TPEX:6815)
Taiwan
· Delayed Price · Currency is TWD 35.50
+5.10 (16.78%)
Apr 29, 2026, 1:59 PM CST
Diamond Biotechnology Market Cap
Diamond Biotechnology has a market cap or net worth of 1.21 billion as of April 28, 2026. Its market cap has decreased by -40.42% in one year.
Market Cap
1.21B
Enterprise Value
1.25B
Revenue
698.11M
Ranking
n/a
PE Ratio
34.26
Stock Price
35.50
Market Cap Chart
Since January 29, 2021, Diamond Biotechnology's market cap has decreased from 1.68B to 1.21B, a decrease of -28.11%. That is a compound annual growth rate of -6.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1.21B | -51.75% |
| Dec 31, 2025 | 2.50B | -7.50% |
| Dec 31, 2024 | 2.71B | 12.05% |
| Dec 29, 2023 | 2.42B | 179.34% |
| Dec 30, 2022 | 864.86M | -11.33% |
| Dec 30, 2021 | 975.37M | -41.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rossmax International | 1.20B |
| AViTA | 1.16B |
| NaviFUS | 1.32B |
| Wiltrom | 1.08B |
| Cowealth Medical Holding | 1.37B |
| Bioptik Technology Incorporation | 1.40B |
| PlexBio | 1.01B |
| S&S Healthcare Holding | 924.54M |